Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 159.00
+15.74 (10.99%)
At close: Sep 30, 2026
Sino Biological,Inc. Revenue
Sino Biological,Inc. had revenue of 209.47M CNY in the quarter ending June 30, 2026, with 23.83% growth. This brings the company's revenue in the last twelve months to 768.00M, up 21.43% year-over-year. In the year 2025, Sino Biological,Inc. had annual revenue of 699.56M with 14.00% growth.
Revenue (ttm)
768.00M
Revenue Growth
+21.43%
P/S Ratio
25.18
Revenue / Employee
718.43K
Employees
1,069
Market Cap
19.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 699.56M | 85.89M | 14.00% |
| Dec 31, 2024 | 613.67M | -32.72M | -5.06% |
| Dec 31, 2023 | 646.39M | 71.79M | 12.49% |
| Jan 1, 2023 | 574.60M | -390.67M | -40.47% |
| Jan 1, 2022 | 965.27M | -631.02M | -39.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Yili Chuanning Biotechnology | 4.37B |
| Xiamen Amoytop Biotech | 4.02B |
| Anhui Anke Biotechnology (Group) | 2.45B |
| Shanghai Medicilon | 1.38B |
| BrightGene Bio-Medical Technology | 1.36B |
| Sinocelltech Group | 1.25B |
| Evopoint Biosciences | 1.11B |
| Acrobiosystems | 950.35M |